Equities

Cannabis Bioscience International Holdings Inc

CBIH:PKC

Cannabis Bioscience International Holdings Inc

Actions
IndustrialsConstruction and Materials
  • Price (USD)0.0006
  • Today's Change0.000 / -7.69%
  • Shares traded8.75m
  • 1 Year change-25.00%
  • Beta-0.0353
Data delayed at least 15 minutes, as of Nov 22 2024 19:42 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company also operates a learning platform that provides knowledge and promotes professionalism in the cannabis industry through education and research about the medical properties and healing values of the plant. Through its Alpha Research Business, based in Houston, Texas, offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients and others who desire to participate in the cannabis industry.

  • Revenue in USD (TTM)354.91k
  • Net income in USD-545.87k
  • Incorporated2003
  • Employees2.00
  • Location
    Cannabis Bioscience International Holdings Inc6201 Bonhomme Road, Suite 435SHOUSTON 77036United StatesUSA
  • Phone+1 (214) 733-0868
  • Websitehttps://www.cbih.net/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Burzynski Research Institute Inc0.00-1.54m6.44m2.00---------0.0117-0.01170.00-0.00070.00-------89,888.89-15,304.89-------------------------45.74------
CNS Pharmaceuticals Inc0.00-17.06m6.44m3.00--1.30-----80.15-80.150.000.10020.00----0.00-350.34-132.47-2,116.75-185.75------------0.0092-------23.42------
Adial Pharmaceuticals Inc0.00-13.03m6.53m4.00--1.11-----4.49-4.500.000.91850.00----0.00-272.04-182.35-316.95-235.45-----------16.220.00------35.14------
Transcode Therapeutics Inc0.00-14.93m6.56m10.00--3.97-----8.49-8.490.000.09570.00----0.00-210.77-133.14-475.23-181.26-----------40.020.00-------5.59------
Brainstorm Cell Therapeutics Inc0.00-14.23m6.59m29.00---------3.46-3.460.00-1.140.00----0.00-369.22-117.19---231.65-----------35.87--------29.18---45.34--
NLS Pharmaceutics AG0.00-6.60m6.66m3.00---------6.72-6.720.00-9.400.00----0.00-380.82-272.62---------------27.20--------26.21------
National Graphite Corp0.00-1.97m6.79m0.00---------0.0221-0.02210.00-0.01930.00-------11,014.44-212.13---6,295.18---------------------1,432.70------
Edesa Biotech Inc0.00-6.93m6.85m16.00--2.39-----2.21-2.210.000.88290.00----0.00-94.60---128.81--------------0.00------52.28------
Cannabis Bioscience Internatnl Hlgs Inc354.91k-545.87k6.86m2.00------19.33-0.00005-0.000050.00003-0.00018.98--15.71177,455.00-1,381.60------87.28---153.81-----2.16-----21.46--36.92------
Virpax Pharmaceuticals Inc0.00-13.24m6.91m7.00---------8.82-8.820.00-0.41980.00----0.00-198.45-87.52-594.46-116.56-----------128.86--------29.84------
Syros Pharmaceuticals Inc386.00k-97.82m6.98m68.00------18.07-3.03-3.030.0105-0.41450.0033----5,676.47-84.04-54.44-111.15-64.32-----25,340.67-772.82---179.011.37---33.2337.12-73.87---27.78--
Biora Therapeutics Inc892.00k-35.57m7.07m58.00------7.93-12.92-11.780.2163-28.990.0363--1.0615,379.31-144.59-122.84---369.01-----3,988.12-415.10---------98.69-87.44-154.63---53.68--
Plus Therapeutics Inc (USA)5.73m-12.89m7.08m20.00------1.24-2.42-2.420.988-0.87750.5653----286,250.00-127.22-59.18---133.04-----225.07-470.45---4.31----2,093.30-5.8934.32--3.77--
ABVC Biopharma Inc509.80k-8.24m7.14m16.00--0.8363--14.00-0.9744-0.97440.05080.65760.0328--1.6031,862.50-56.14-103.38-88.09-231.5472.5476.25-1,710.03-2,019.89---2.620.1856---84.2885.3935.97------
Intelligent Bio Solutions Inc3.19m-10.42m7.19m13.00--1.18--2.26-27.94-27.941.421.390.31211.935.56245,228.50-102.35-71.59-255.70-144.3648.31---327.90-565.481.01--0.0775--147.58596.394.47------
Data as of Nov 22 2024. Currency figures normalised to Cannabis Bioscience International Holdings Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.